ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Gets Less Press, Study Finds

May 18, 2001

USPSTF’s Michael LeFevre: Lung Screening Can Save More Lives With Fewer Screens Than Mammography

August 2, 2013

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009